We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

48 hedge funds and large institutions have $92.3M invested in Assembly Biosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 52 → 48 (-4)

22% less capital invested

Capital invested by funds: $118M → $92.3M (-$26M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
18
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$1.92M
2
VAM
Visium Asset Management
New York
+$908K
3
William Blair & Company
William Blair & Company
Illinois
+$244K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$208K
5
CC
Caxton Corporation
New Jersey
+$164K

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$3.05M
2
Morgan Stanley
Morgan Stanley
New York
-$536K
3
Millennium Management
Millennium Management
New York
-$240K
4
PP
PDT Partners
New York
-$207K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$189K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$156K – – –
BRWA
27
B. Riley Wealth Advisors
Florida
$145K – – –
CC
28
Caxton Corporation
New Jersey
$136K +$164K +1,508 New
Bank of America
29
Bank of America
North Carolina
$126K +$2.72K +25 +2%
GCP
30
GSA Capital Partners
United Kingdom
$113K – – –
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$112K +$135K +1,242 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$106K +$12.7K +117 +11%
State Board of Administration of Florida Retirement System
33
State Board of Administration of Florida Retirement System
Florida
$100K – – –
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$98K – – –
Renaissance Technologies
35
Renaissance Technologies
New York
$89K +$108K +992 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$84K – – –
CS
37
Credit Suisse
Switzerland
$76K +$91.4K +839 New
NFA
38
Nationwide Fund Advisors
Ohio
$68K – – –
AIG
39
American International Group
New York
$63K -$109 -1 -0.1%
BA
40
BlackRock Advisors
Delaware
$48K -$29.2K -268 -33%
Deutsche Bank
41
Deutsche Bank
Germany
$35K +$7.3K +67 +20%
Morgan Stanley
42
Morgan Stanley
New York
$29K -$536K -4,923 -94%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$19.6K -$6.75K -62 -22%
Wells Fargo
44
Wells Fargo
California
$11K +$12.5K +115 +1,917%
TRCT
45
Tower Research Capital (TRC)
New York
$10K +$109 +1 +0.9%
Citigroup
46
Citigroup
New York
$8K -$763 -7 -8%
UBS Group
47
UBS Group
Switzerland
$3K +$3.05K +28 New
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$75 – – –
HM
49
HealthCor Management
New York
– -$3.05M -26,552 Closed
PP
50
PDT Partners
New York
– -$207K -1,800 Closed
1
2
3

ASMB Hedge Fund Activity: Q4 2015 in Review

48 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2015, worth a combined $92.3M — down 22% from $118M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ASMB and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 18 added.

The largest buyer was EcoR1 Capital, adding an estimated $1.92M. The largest seller was HealthCor Management, exiting entirely with an estimated $3.05M sold.

  • 48 institutional investors held Assembly Biosciences (ASMB) as of Q4 2015, down from 52 in Q3 2015.
  • Funds reported $92.3M of Assembly Biosciences stock for Q4 2015, down 22% quarter-over-quarter.
  • 5 funds opened new Assembly Biosciences positions in Q4 2015 and 9 closed out, a net change of -4 holders.
  • The largest Assembly Biosciences buyer in Q4 2015 was EcoR1 Capital, an estimated $1.92M added.
  • The largest Assembly Biosciences seller in Q4 2015 was HealthCor Management, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2015.